What is the relationship between medullary sponge kidney (MSK) and the predisposition to nephrolithiasis (kidney stones)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Medullary sponge kidney (MSK) is a congenital disorder that predisposes individuals to kidney stones due to the cystic dilation of the collecting ducts in the renal medulla, which creates an ideal environment for crystal formation and concentration of stone-forming substances. This condition is characterized by the trapping of urine in the dilated collecting ducts, allowing it to stagnate and become concentrated, increasing the concentration of stone-forming substances like calcium, oxalate, and phosphate 1. The cystic structures themselves can serve as nucleation sites for crystals, and the altered anatomy disrupts normal urinary flow, preventing small crystals from being flushed out before they grow into stones. Most patients with MSK develop recurrent kidney stones, typically calcium-based, and may experience symptoms like flank pain, hematuria, and urinary tract infections. Management focuses on preventing stone formation through increased fluid intake, with a goal of at least 2.5 liters of urine daily, as recommended by the American Urological Association 1. Dietary modifications, such as limiting sodium intake and consuming 1,000-1,200 mg per day of dietary calcium, can also help reduce the risk of stone formation 1. Additionally, medications like thiazide diuretics may be used to reduce urinary calcium excretion, as recommended by the American College of Physicians 1. Some key points to consider in the management of MSK include:

  • Increased fluid intake to achieve a urine volume of at least 2.5 liters daily
  • Dietary modifications to reduce stone-forming substances, such as limiting sodium intake and consuming adequate dietary calcium
  • Medications like thiazide diuretics to reduce urinary calcium excretion
  • Avoiding supplemental calcium, which may be associated with an increased risk of stone formation 1. It is essential to note that the management of MSK should be individualized, taking into account the patient's specific needs and risk factors, and that a comprehensive approach that includes lifestyle modifications and medical therapy can help reduce the risk of recurrent kidney stones.

From the Research

Definition and Characteristics of Medullary Sponge Kidney

  • Medullary Sponge Kidney (MSK) is a rare congenital malformation of the distal nephron where cystic dilatation is appreciable in the collecting ducts and renal papillae 2.
  • MSK is generally considered a sporadic disorder, but an apparently autosomal dominant inheritance has also been observed 3.
  • The disease is characterized by abnormalities in both the lower and the upper nephron and is often associated with urinary tract developmental anomalies 3.

Predisposition to Kidney Stones

  • MSK predisposes people to kidney stones due to a defective distal acidification, which is followed by a chain of events including defective bone mineralization, hypercalciuria, hypocitraturia, and stone formation 3.
  • The disease can lead to nephrocalcinosis and recurrent renal stones, as well as other signs such as renal acidification and concentration defects, and pre-calyceal duct ectasias 3.
  • Patients with MSK are at risk of developing an obstructive nephropathy due to recurrent stone formation and passage 4.

Diagnosis and Treatment

  • Diagnosis of MSK can be made using intra-venous urogram (IVU), endoscopy, and Multi-detector computed tomography (MDCT) 2.
  • Treatment options for MSK include non-invasive treatments such as drug therapy, diet, and extracorporeal shock wave lithotripsy, as well as invasive therapies such as percutaneous nephrolithotomy, ureteroscopy, and surgery 5.
  • The aim of treatment is to control stone formation by stabilizing urinary pH, and to remove symptomatic kidney stones using methods such as lithotripsy or surgical intervention 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Medullary Sponge Kidney: Current Perspectives.

International journal of nephrology and renovascular disease, 2019

Research

Medullary sponge kidney: state of the art.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013

Research

Medullary sponge kidney: causes and treatments.

British journal of nursing (Mark Allen Publishing), 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.